Dementia in the News

December 13, 2017

Boston Globe (December 13, 2017): Bostonian of the Year 2017: The Concussion Researcher

CONGRATULATIONS TO DR. ANN MCKEE -- OUR FORMER NEUROPATHOLOGY FELLOW!

AT A SHOE DEALER CONVENTION in Boston in 1920, Dr. Jacob Lowe showed off an invention he called the Foot-O-Scope. His fluoroscope used an X-ray tube to produce a fluorescent image of the bones in a foot as well as the shoe around it, ensuring a perfect fit. It was a modification of a device the Boston physician created during World War I to examine the injured feet of servicemen without removing their boots.

December 11, 2017

EurekAlert (December 11, 2017): Up to $70 Million to be Awarded to Advance Alzheimer's Disease Clinical Trials

The National Institutes of Health (NIH) is expected to award up to $70 million over five years to three physician-scientists to launch the Alzheimer's Clinical Trials Consortium (ACTC), which will create a network of 35 Alzheimer's disease trial sites across the country with the goal of finding new ways to treat or prevent Alzheimer's.

December 8, 2017

MGH NeuroBlast (December 4, 2017): Massachusetts General Hospital's NPH Program Offers Comprehensive Evaluation & Treatment of Brain Disorder

At 79, Tamar wasn’t ready to slow down: She walked three miles a day, was a whiz at Sudoku puzzles, and loved hiking with her husband. But within just a year, she had sharply declined. The once-vibrant septuagenarian could no longer get out of a chair unassisted, didn’t understand how to use a telephone, and had become incontinent. “She was a shell of her former self,” remembers her daughter Iris. “Her physician told us that she had atypical Alzheimer’s disease and that nothing could be done for her.”

November 28, 2017

MGH Research Institute (November 28, 2017): Gatchel Untangles the Causes of Mood & Anxiety Symptoms & Loss of Brain Function in Aging Populations

Often referred to as the golden years, life after retirement can sometimes turn out to be less than sunny.

Dramatic lifestyle changes such as admittance to an assisted care facility and loss of mobility or independence can take a toll on mental health.

In fact, twenty percent of people over 55 suffer from a mental disorder, and two-thirds of nursing home residents exhibit mental and behavioral problems.

November 21, 2017

National Institute on Aging (November 21, 2017): Holiday Hints for Alzheimer's Caregivers

Holidays can be meaningful, enriching times for both the person with Alzheimer’s disease and his or her family. Maintaining or adapting family rituals and traditions helps all family members feel a sense of belonging and family identity. For a person with Alzheimer’s, this link with a familiar past is reassuring.

November 13, 2017

Washington Post (November 13, 2017): Bill Gates Joins the Fight Against Alzheimer’s — and It’s Personal

Billionaire Bill Gates is personally investing $50 million to help fund research to find a treatment for Alzheimer’s disease, a type of dementia that Gates says has struck members of his own family.

There is no cure for Alzheimer’s, which destroys memory and other mental processes, and so Gates said he is investing his own money into the Dementia Discovery Fund, a private-public partnership to search for a solution.

November 8, 2017

Alzheimer's Association (November 6, 2017): The Building Our Largest Dementia (BOLD) Infrastructure Act introduced in House & Senate

The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act, new bipartisan legislation prioritizing our nation’s approach to Alzheimer’s disease. The BOLD Infrastructure for Alzheimer’s Act was introduced by Senators Susan Collins (R-Maine), Catherine Cortez Masto (D-Nev.), Shelley Moore Capito (R-W.Va.), Tim Kaine (D-Va.), and by Representatives Brett Guthrie (R-Ky.), Paul Tonko (D-N.Y.), Chris Smith (R-N.J.) and Maxine Waters (D-Calif.).

November 8, 2017

MGH Research (October 30, 2017): How a 3D Model of Alzheimer’s Disease is Providing New Hope in the Search for Treatments

Reigning in Alzheimer’s disease continues to be a challenge — more than 10 million families are affected by this degenerative neurological disease, and the number of patients dying from the disease has increased 68 percent since 2010.

In the past decade, attempts at developing drugs to slow or halt the progression of Alzheimer’s disease have been unsuccessful. The traditional path for early testing of promising therapies – mouse models – has been ineffective, and more than a dozen major clinical trials have failed.

November 2, 2017

U.S. Postal Service (November 2, 2017): U.S. Postal Service Previews Alzheimer’s Semipostal Fundraising Stamp Image

The U.S. Postal Service previewed the image of the Alzheimer’s Semipostal fundraising stamp today.

It also announced the stamp will be dedicated at 10 a.m., Thursday, Nov. 30 at Johns Hopkins Asthma & Allergy Center Atrium, Johns Hopkins Bayview Medical Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224.

Pages

Subscribe to Latest News